Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation

References

• CookHLPatelPJTufailAAge-related macular degeneration: diagnosis and managementBr Med Bull20088512714918334518
   PubMed Web of Science ®Google Scholar
• ReinDBWittenbornJSZhangXForecasting age-related macular degeneration through the year 2050: the potential impact of new treatmentsArch Ophthalmol200912753354019365036
   PubMedGoogle Scholar
• HondaSKurimotoYKagotaniYPhotodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo, JapanJpn J Ophthalmol20095359359720020237
   PubMed Web of Science ®Google Scholar
• HondaSImaiHYamashiroKComparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, JapanOphthalmologica200922333333819478533
   PubMed Web of Science ®Google Scholar
• LimJYLeeSYKimJGLeeJYChungHYoonYHIntravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical studyActa Ophthalmol2010 [Epub ahead of print.]
   Web of Science ®Google Scholar
• BosciaFFurinoCSborgiaLReibaldiMSborgiaCPhotodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachmentAm J Ophthalmol20041381077107915629318
   PubMed Web of Science ®Google Scholar
• BosciaFParodiMBFurinoCReibaldiMSborgiaCPhotodynamic therapy with verteporfin for retinal angiomatous proliferationGraefes Arch Clin Exp Ophthalmol20062441224123216525824
   PubMed Web of Science ®Google Scholar
• KrebsIKreplerKStolbaUGollABinderSRetinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT aloneGraefes Arch Clin Exp Ophthalmol200824623724317674018
   PubMed Web of Science ®Google Scholar
• GuptaBJyothiSSivaprasadSCurrent treatment options for retinal angiomatous proliferans (RAP)Br J Ophthalmol20109467267719897475
   PubMed Web of Science ®Google Scholar
• RouvasAAPapakostasTDVavvasDIntravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective studyRetina20092953654419190547
   PubMed Web of Science ®Google Scholar
• SaitoMShiragamiCShiragaFKanoMIidaTComparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferationAm J Ophthalmol201014947248120053392
   PubMed Web of Science ®Google Scholar
• Ruiz-MorenoJMMonteroJABarileSZarbinMAPhotodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcomeRetina20062660261216829800
   PubMed Web of Science ®Google Scholar
• MonteroJARuiz-MorenoJMSanabriaMRFernandez-MunozMEfficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferationBr J Ophthalmol20099316617018971240
   PubMed Web of Science ®Google Scholar
• MoraPEperonSFelt-BaeyensOTrans-scleral diffusion of triamcinolone acetonideCurr Eye Res20053035536116020266
   PubMed Web of Science ®Google Scholar
• LeeSJKimESGeroskiDHMcCareyBEEdelhauserHFPharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyesInvest Ophthalmol Vis Sci2008494506451418503001
   PubMed Web of Science ®Google Scholar
• YannuzziLANegraoSIidaTRetinal angiomatous proliferation in age-related macular degenerationRetina20012141643411642370
   PubMed Web of Science ®Google Scholar
• TatarOAdamAShinodaKInfluence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degenerationRetina20072771372317621180
   PubMed Web of Science ®Google Scholar
• TatarOAdamAShinodaKExpression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapyAm J Ophthalmol20061429510416815256
   PubMed Web of Science ®Google Scholar
• PenfoldPLWenLMadiganMCKingNJProvisJMModulation of permeability and adhesion molecule expression by human choroidal endothelial cellsInvest Ophthalmol Vis Sci2002433125313012202538
   PubMed Web of Science ®Google Scholar
• HoriYHuDEYasuiKSmitherRLGreshamGAFanTPDifferential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implantsBr J Pharmacol1996118158415918842418
   PubMed Web of Science ®Google Scholar
• DebefveEPegazBBalliniJPvan den BerghHCombination therapy using verteporfin and ranibizumab; optimizing the timing in the CAM modelPhotochem Photobiol2009851400140819706144
   PubMed Web of Science ®Google Scholar
• SaitoMIidaTKanoMCombined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferationAm J Ophthalmol2011 [Epub ahead of print]
   Google Scholar
• ShenLYouYSunSChenYQuJChengLIntraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon applicationOphthalmology20101172365237120678801
   PubMed Web of Science ®Google Scholar
• Reche-FrutosJCalvo-GonzalezCDonate-LopezJRetinal angiomatous proliferation reactivation 6 months after high-dose intravitreal acetonide triamcinolone and photodynamic therapyEur J Ophthalmol20071797998218050128
   PubMed Web of Science ®Google Scholar
• HiranoYItoTNozakiMIntraocular pressure elevation following triamcinolone acetonide administration as related to administration routesJpn J Ophthalmol20095351952219847609
   PubMed Web of Science ®Google Scholar
• KonstantinidisLMameletziEMantelIPournarasJAZografosLAmbresinAIntravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP)Graefes Arch Clin Exp Ophthalmol20092471165117119404661
   PubMed Web of Science ®Google Scholar
• HemeidaTSKeanePADustinLSaddaSRFawziAALong-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferationBr J Ophthalmol20109470170519854733
   PubMed Web of Science ®Google Scholar
• ViolaFMapelliCVillaniESequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferationEye (Lond)2010241344135120339389
   PubMed Web of Science ®Google Scholar
• ParodiMBIaconoPMenchiniFIntravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferationActa Ophthalmol2011 [Epub ahead of print]
   Google Scholar